Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Cathepsin B aggravates atheros...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Cathepsin B aggravates atherosclerosis in ApoE-deficient mice by modulating vascular smooth muscle cell pyroptosis through NF-κB / NLRP3 signaling pathway

Bibliographic Details
Published in:PLoS ONE
Main Authors: Hui Li, Quanwei Zhao, Danan Liu, Bo Zhou, Fujun Liao, Long Chen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760722/?tool=EBI
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760722/?tool=EBI

Similar Items

  • Attenuating Atherosclerosis through Inhibition of the NF-κB/NLRP3/IL-1β Pathway-Mediated Pyroptosis in Vascular Smooth Muscle Cells (VSMCs)
    by: Shihuan Li, et al.
    Published: (2024-01-01)
  • Desulfovibrio desulfuricans aggravates atherosclerosis by enhancing intestinal permeability and endothelial TLR4/NF-κB pathway in Apoe−/− mice
    by: Kun Zhang, et al.
    Published: (2023-01-01)
  • Regulation of pyroptosis by NF-κB signaling
    by: Ling Yang, et al.
    Published: (2025-01-01)
  • Cathepsin K contributed to disturbed flow-induced atherosclerosis is dependent on integrin-actin cytoskeleton–NF–κB pathway
    by: Fei Fang, et al.
    Published: (2023-03-01)
  • Microplastics Exposure Aggravates Synovitis and Pyroptosis in SLE by Activating NF-κB and NRF2/KEAP1 Signaling
    by: Wenxiang Zeng, et al.
    Published: (2024-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs